Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 941-787-9 | CAS number: 98222-50-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Toxicokinetic Assessment
Absorption
Oral route
Treatment-related changes in the liver and kidney of rats receiving a daily oral dose of DAILUBE IS-30 indicates that the substance was absorbed systemically. The molecular weight of the test item will allow passive diffusion across biological membranes within the gastro- intestinal tract but this passive diffusion will be limited by the low water solubility of the test item. The high log Octanol:Water partition coefficient suggests that the test item can cross biological membranes via a selective uptake process. The limitations of absorption can explain the lack of toxicity observed in a single high dose acute oral toxicity study or may reflect lack of inherent toxicity associated with the test item
Dermal route
A single dose acute dermal toxicity study failed to demonstrate systemic effects in rats. The molecular weight and potential lipid solubility of the test item does not preclude the absorption via the dermis but either the limitations of absorption or the lack of systemic toxicity may suggest that the test material exposure via dermal absorption is likely to have negligible impact upon animals.
Inhalation route
The test item is a liquid with a relatively low vapour pressure value which suggests that inhalation of volatile components of the test item is not likely to occur. The physical characteristics of the test item suggest that there will be no inhalation of particles of the test item. Absorption across the respiratory membranes is likely to be limited by the high partition coefficient and low water solubility.
Distribution
The results of repeated dose toxicity testing indicate that some systemic distribution of the test item does take place. As the circulatory media are essentially a water based component, the limitations of distribution due to the limited water solubility of the test item will be a factor in the rate of systemic distribution. The lack of sensitization response in mice using the local Lymph Node Assay suggests that the test item is unlikely to bind to circulatory proteins in blood. The high log Octanol:Water partition coefficient value suggests that the test item has the capacity to bind to body fat. Accumulation of test item in body fat is therefore a potential event.
Metabolism
The results of histopathological evaluation of livers of rats from the repeated dose/reproduction and developmental toxicity screening assay shows evidence of hepatocyte enlargement in rats. The observation of an increase in endoplasmic reticulum in the livers of treated rats confirms the belief that induction of hepatic metabolising systems has occurred in response to exposure to the test item. It can be expected that excretion of non-water soluble xenobiotics such as the test item will be facilitated by metabolism (both phase I and II ) in the liver. The hepatic induction is seen as an adaptive change to prolonged test item exposure. The lack of genotoxicity in vitro (Mutagenesis in bacteria and mammalian cells and clastogenicity in mammalian cells) suggest that any metabolism via the S9 metabolising system does not result in an alteration of effects on these systems
Excretion
The histopathological observations from the repeated dose/reproduction toxicity assay showed evidence of renal changes associated with accumulation of α2µ globulin. It may be possible to suggest that the test item is being excreted via the kidney following rendering of the test item more soluble following hepatic metabolism. The renal effect is primarily a rodent phenomenon and is consider an adaptive response. This may therefore be of no relevance for human exposure. It does however indicate the most likely route of excretion of the test item. Any unabsorbed test material, following oral administration will be excreted via faeces.
Conclusion
The results of the rodent toxicity assays demonstrate evidence of test item absorption, distribution, metabolism and excretion. The rates of these processes are limited by the physicochemical characteristics of the test item.
Key value for chemical safety assessment
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.